M. Luiza-baggio, L. Galan, J. Simão-sobrinho, J. Carlos-mann-prado, S. Ferreira et al., Affiliated with McGill University in Montreal, Cancer Research in Sao PauloPrincipal Investigator)

H. Kitchener, P. Castle, and T. Cox, Chapter 7: Achievements and limitations of cervical cytology screening, Vaccine, vol.24, issue.3S3S3, pp.63-66, 2006.
DOI : 10.1016/j.vaccine.2006.05.113

J. Cuzick, C. Clavel, K. Petry, C. Meijer, H. Hoyer et al., Overview of the European and North American studies on HPV testing in primary cervical cancer screening, International Journal of Cancer, vol.93, issue.5, pp.1095-101, 2006.
DOI : 10.1002/ijc.21955

M. Arbyn, C. Bergeron, P. Klinkhamer, P. Martin-hirsch, A. Siebers et al., Liquid Compared With Conventional Cervical Cytology, Obstetrics & Gynecology, vol.111, issue.1, pp.167-77, 2008.
DOI : 10.1097/01.AOG.0000296488.85807.b3

M. Arbyn, R. Sankaranarayanan, R. Muwonge, N. Keita, A. Dolo et al., Pooled analysis of the accuracy of five cervical cancer screening tests assessed in eleven studies in Africa and India, International Journal of Cancer, vol.97, issue.1, pp.153-60, 2008.
DOI : 10.1002/ijc.23489

M. Arbyn, P. Sasieni, C. Meijer, C. Clavel, G. Koliopoulos et al., Chapter 9: Clinical applications of HPV testing: A summary of meta-analyses, Vaccine, vol.24, issue.3S3, pp.78-81, 2006.
DOI : 10.1016/j.vaccine.2006.05.117

E. Franco, M. Mayrand, E. Duarte-franco, I. Rodrigues, S. Walter et al., Human papillomavirus DNA versus papanicolaou screening tests for cervical cancer, N Engl J Med, vol.357, issue.16, pp.1579-88, 2007.

J. Dillner, M. Rebolj, P. Birembaut, K. Petry, A. Szarewski et al., Long term predictive values of cytology and human papillomavirus testing in cervical cancer screening: joint European cohort study, BMJ, vol.337, issue.oct13 1, 2008.
DOI : 10.1136/bmj.a1754

H. Katki, W. Kinney, B. Fetterman, T. Lorey, N. Poitras et al., Cervical cancer risk for women undergoing concurrent testing for human papillomavirus and cervical cytology: a population-based study in routine clinical practice, The Lancet Oncology, vol.12, issue.7, pp.663-72, 2011.
DOI : 10.1016/S1470-2045(11)70145-0

N. Bulkmans, J. Berkhof, L. Rozendaal, F. Van-kemenade, A. Boeke et al., Human papillomavirus DNA testing for the detection of cervical intraepithelial neoplasia grade 3 and cancer: 5-year follow-up of a randomised controlled implementation trial, The Lancet, vol.370, issue.9601, pp.796-802, 2007.
DOI : 10.1016/S0140-6736(07)61450-0

M. Durst, H. Hoyer, C. Scheungraber, R. Kuehne-heid, K. Teller et al., Cumulative 5-year diagnoses of CIN2, CIN3 or cervical cancer after concurrent high-risk HPV and cytology testing in a primary screening setting, Int J Cancer, vol.116, issue.1, pp.136-179, 2005.

M. Sherman, A. Lorincz, D. Scott, S. Wacholder, P. Castle et al., Baseline Cytology, Human Papillomavirus Testing, and Risk for Cervical Neoplasia: A 10-Year Cohort Analysis, JNCI Journal of the National Cancer Institute, vol.95, issue.1, pp.46-52, 2003.
DOI : 10.1093/jnci/95.1.46

E. Franco, L. Villa, T. Rohan, A. Ferenczy, M. Petzl-erler et al., Design and methods of the Ludwig-McGill longitudinal study of the natural history of human papillomavirus infection and cervical neoplasia in Brazil, Revista Panamericana de Salud P??blica, vol.6, issue.4, pp.223-256, 1999.
DOI : 10.1590/S1020-49891999000900001

N. Schlecht, S. Kulaga, J. Robitaille, S. Ferreira, M. Santos et al., Persistent Human Papillomavirus Infection as a Predictor of Cervical Intraepithelial Neoplasia, JAMA, vol.286, issue.24, pp.3106-3120, 2001.
DOI : 10.1001/jama.286.24.3106

E. Kaplan and P. Meier, Nonparametric Estimation from Incomplete Observations, Journal of the American Statistical Association, vol.37, issue.282, pp.457-81, 1958.
DOI : 10.1214/aoms/1177731566

D. Cox, Regression Models and Life-Tables, J R Stat Soc B, vol.34, issue.2, pp.187-220, 1972.
DOI : 10.1007/978-1-4612-4380-9_37

L. Massad, Y. Collins, and P. Meyer, Biopsy Correlates of Abnormal Cervical Cytology Classified Using the Bethesda System, Gynecologic Oncology, vol.82, issue.3, pp.516-538, 2001.
DOI : 10.1006/gyno.2001.6323

T. Wright, S. Massad, C. Dunton, M. Spitzer, E. Wilkinson et al., 2006 consensus guidelines for the management of women with abnormal cervical cancer screening tests, American Journal of Obstetrics and Gynecology, vol.197, issue.4, pp.346-55, 2006.
DOI : 10.1016/j.ajog.2007.07.047

N. Schlecht, Longitudinal relationship between human papillomavirus infection and the incidence and progression of precursor lesions of cervical neoplasia, 2002.

M. Stoler and M. Schiffman, Interobserver Reproducibility of Cervical Cytologic and Histologic Interpretations<SUBTITLE>Realistic Estimates From the ASCUS-LSIL Triage Study</SUBTITLE>, JAMA, vol.285, issue.11, pp.1500-1505, 2001.
DOI : 10.1001/jama.285.11.1500

J. Melnikow, J. Nuovo, A. Willan, B. Chan, and L. Howell, NATURAL HISTORY OF CERVICAL SQUAMOUS INTRAEPITHELIAL LESIONS, Obstetrics & Gynecology, vol.92, issue.Supplement, pp.727-762, 1998.
DOI : 10.1097/00006250-199810001-00046